NLRP3-driven production of IL-1β and IL-18 contributes to the tissue damage observed in various autoimmune and autoinflammatory diseases, such as gout, rheumatoid arthritis, type 2 diabetes mellitus, cardiovascular disorders, and infectious diseases [348–352]. Here, NLRP3 is linked to type 2 diabetes mellitus.